Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Risk | NA | NA |
Rating | 4.0 | 4.0 |
Min SIP Amount | ₹100 | ₹100 |
Expense Ratio | 1.72 | 1.74 |
NAV | ₹75.91 | ₹81.58 |
Fund Started | 16 Feb 2004 | 17 Nov 2003 |
Fund Size | ₹3237.02 Cr | ₹3387.60 Cr |
Exit Load | Exit load for units in excess of 30% of the investment,1% will be charged for redemption within 1 year | Exit load for units in excess of 15% of the investment, 1% will be charged for redemption within 1 year |
Risk
Rating
Min SIP Amount
Expense Ratio
NAV
Fund Started
Fund Size
Exit Load
1 Year | 7.20% | 4.21% |
3 Year | 10.12% | 10.27% |
5 Year | 9.98% | 11.11% |
1 Year
3 Year
5 Year
Equity | 22.26% | 19.74% |
Cash | 5.50% | 4.22% |
Equity
Cash
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
---|---|
ICICI Bank Ltd. | 1.70% |
SBI Life Insurance Company Ltd. | 1.36% |
Maruti Suzuki India Ltd. | 1.14% |
Sun Pharmaceutical Industries Ltd. | 1.07% |
HDFC Bank Ltd. | 1.06% |
Hindustan Unilever Ltd. | 0.94% |
NTPC Ltd. | 0.93% |
Axis Bank Ltd. | 0.83% |
HDFC Life Insurance Co Ltd. | 0.78% |
Infosys Ltd. | 0.77% |
Name | Assets |
---|---|
ICICI Bank Ltd. | 2.19% |
HDFC Bank Ltd. | 2.09% |
State Bank of India | 1.18% |
Reliance Industries Ltd. | 1.03% |
Axis Bank Ltd. | 1.03% |
Bharti Airtel Ltd. | 0.79% |
Infosys Ltd. | 0.76% |
Sun Pharmaceutical Industries Ltd. | 0.76% |
Larsen & Toubro Ltd. | 0.75% |
ITC Ltd. | 0.73% |
Name | Ritesh Lunawat | Dhruv Muchhal |
Start Date | 28 Dec 2020 | 14 Sep 2023 |
Name
Start Date
Description | The scheme seeks to generate long-term capital appreciation by investments in money market and debt instruments. | The scheme seeks to generate income/capital appreciation by investing primarily in debt securities, money market instruments and moderate exposure to equities. |
Launch Date | 16 Feb 2004 | 17 Nov 2003 |
Description
Launch Date